ANDA 212332, held by Hainan Poly. Vancomycin Hydrochloride.
As of Nov 16, 2026, ANDA 212332 (Vancomycin Hydrochloride), held by Hainan Poly, was first approved by FDA on Jun 12, 2019, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 12, 2019 | Original application | Approved | None posted |
| Vancomycin HydrochlorideEQ 500MG BASE/VIAL · injectable;injection | Vancomycin Hydrochloride | Rx |
| Vancomycin HydrochlorideEQ 1GM BASE/VIAL · injectable;injection | Vancomycin Hydrochloride | Rx |
| Apr 7, 2021 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jun 12, 2019 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters